Aurora Investment Counsel Acquires Shares of 20,867 The Cooper Companies, Inc. $COO

Key Points

• Aurora Investment Counsel bought 20,867 shares of Cooper Companies during the second quarter, valued at approximately $1.5 million. Institutional investors collectively own 24.39% of the company.
• Cooper Companies reported quarterly earnings of $1.21 per share, beating estimates of $1.10, while revenue rose 7.9% year over year to $1.08 billion. The company issued fiscal 2026 EPS guidance of $4.58–$4.66.
• Analyst sentiment is mixed, with the stock carrying a consensus rating of “Hold” and an average price target of $81.64. Several firms recently cut their targets, despite multiple analysts maintaining Buy or Outperform ratings.

Aurora Investment Counsel purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 20,867 shares of the medical device company's stock, valued at approximately $1,496,000.

Other large investors also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company's stock worth $1,890,000 after purchasing an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its position in Cooper Companies by 115.8% in the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company's stock valued at $9,702,000 after purchasing an additional 73,165 shares during the period. Cresset Asset Management LLC acquired a new position in Cooper Companies during the 2nd quarter worth about $291,000. Cerity Partners LLC lifted its position in shares of Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company's stock worth $1,272,000 after purchasing an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its holdings in Cooper Companies by 2.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company's stock worth $2,551,000 after buying an additional 973 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

NASDAQ COO opened at $76.73 on Thursday. The company has a market capitalization of $14.96 billion, a PE ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The business's 50-day moving average price is $71.59 and its 200 day moving average price is $71.16.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to analysts' expectations of $1.05 billion. During the same quarter last year, the firm earned $0.96 earnings per share. The firm's revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on COO. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research report on Wednesday, May 27th. Weiss Ratings downgraded shares of Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research note on Monday, June 8th. Needham & Company LLC lowered their target price on shares of Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research report on Friday, June 5th. Robert W. Baird lowered their price target on Cooper Companies from $98.00 to $85.00 and set an "outperform" rating on the stock in a report on Friday, June 5th. Finally, Wells Fargo & Company reissued a "sell" rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source